NDAINJECTIONINJECTABLEPriority Review
Approved
Jun 1988
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
14
Clinical Trials (5)
Gadobutrol Magnevist-controlled Body Study
Started Jan 2010
370 enrolled
Magnetic Resonance Imaging
Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist
Started Nov 2008
168 enrolled
FibrosisKidney FailureRenal Insufficiency
Magnevist Post-marketing Surveillance in Japan
Started Aug 2007
2,051 enrolled
Diagnostic Imaging
Multihance Versus Magnevist in Breast MRI
Started Jul 2007
130 enrolled
Breast Cancer
Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients
Started Oct 2006
83 enrolled
Vascular Diseases